Comprehensive safety analysis of the clinical spectrum of adverse events associated with immune checkpoint inhibitors based on FAERS - Takeaways - MDSpire

Comprehensive safety analysis of the clinical spectrum of adverse events associated with immune checkpoint inhibitors based on FAERS

  • By

  • Caihong Qu

  • Xiaoying Wang

  • May 1, 2026

  • 0 min

Share

  • 1

    The study analyzed 320,556 adverse event reports linked to eight immune checkpoint inhibitors from the FAERS database.

  • 2

    Endocrine and hepatobiliary disorders showed the strongest adverse event signals, while cardiac and respiratory toxicities had the highest mortality risks.

  • 3

    Prominent adverse event signals included noninfectious encephalitis, hypothyroidism, and immune-mediated myocarditis among others.

  • 4

    The research provides a systematic evaluation of immune-related adverse events across multiple organ systems over an extended period.

  • 5

    This study aims to enhance clinician understanding of ICI-related toxicities and promote interdisciplinary collaboration for management.

Original Source(s)

Related Content